Immunoglobulin G: Functional sites

Molecular Immunology

Volumn 22, Issue 3, 1985, Pages 161-206

  Burton, Dennis R ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN G; PROTEIN A;

NONHUMAN; PRIORITY JOURNAL; REVIEW; SURVEY;

AMINO ACID SEQUENCE; ANIMAL; BINDING SITES, ANTIBODY; CARBOHYDRATES; COMPLEMENT; GUINEA PIGS; HUMAN; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, FAB; IMMUNOGLOBULINS, FC; LYMPHOCYTES; MACROPHAGES; MICE; MODELS, MOLECULAR; MONOCYTES; NEUTROPHILS; PLACENTA; PROTEIN CONFORMATION; RABBITS; RECEPTORS, FC; STEREOISOMERISM; SUPPORT, NON-U.S. GOV'T;

EID: 0021857415     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/0161-5890(85)90151-8     Document Type: Article

References (223)

1. The carbohydrate content of fragments and polypeptide chains of human γG-myeloma protein of different heavychain subclasses
2. The interaction between human monocytes and red cells. Specificity for IgG subclasses and IgG fragments
3. 2 fragment for activation of the complement system through the alternative pathway. I. Disulfide bonds
4. The binding of human and guinea pig IgG subclasses to homologous macrophages and monocyte receptors
5. Cytophilic activity of enzymatically derived fragments of guinea pig IgG2
6. The first component of human complement from the bullfrog Rana catesbeiana: functional properties of Cl and isolation of subcomponent C1q
7. Fixation of frog and guinea pig complement by antibodies from the bullfrog Rana catesbeiana
8. Characterization of the Fc receptor for IgG on a human macrophage cell line, U937
9. The reaction of monomeric and aggregated immunoglobulin with Cl
10. The structure and function of immunoglobulin domains VII Studies on the structural requirements of human IgG for granulocyte binding
11. Structure and function of immunoglobulin domains VIII An analysis of the structural requirements in human IgG1 for binding to the Fc receptor of human monocytes
12. The interaction of the Facb fragment of rabbit anti-sheep red cell IgG with guinea pig macrophages and human monocytes and granulocytes
13. The effect of fragment B and staphylococcal protein A on the binding of rabbit IgG to human granulocytes and monocytes
14. Mechanism of antibody independent activation of the first component of complement (C) on retrovirus membranes
15. Structure and function of the constant region of immunoglublins
16. Effects of immunoglobulin structure on Fc receptor binding: a mouse myeloma variant immunoglobulin with a γ2b-γ2a hybrid heavy chain having a complete γ2a Fc region fails to bind to γ2a Fc receptors on mouse macrophages
17. Recovery of native conformation of rabbit immunoglobulin G upon recombination of separately renatured heavy and light chains at near-neutral pH
18. An IgG primary sequence exposure theory for complement activation using synthetic peptides
19. Specificity of Fc receptors for IgG2a, IgG1/IgG2b and IgE on rat macrophages
20. 2 subunit of first component of human complement in solution
21. γ fragment—II. Location of acidic residues involved in complement activation
22. Fcγ-receptor activity of isolated human placental syncytiotrophoblast plasma membrane
23. Mediation of effector functions by antibodies, Report of a workshop
24. Isotypes of IgG: comparison of the primary structures of three pairs of isotypes which differ in their ability to activate complement
25. The C1q receptor site on immunoglobulin G
26. Human monocyte binding of homologous and complexed IgG
27. Interactions between mouse immunoglobulins and staphylococcal protein A
28. The role of the interheavy chain disulphide bond in modulating the flexibility of immunoglobulin G antibody
29. Hydrophobic bonding and accessible surface area in proteins
30. Localization of the IgG effector site for monocyte receptors
31. Characterization of a plasmin-digest fragment of rabbit immunoglobulin gamma that binds antigen and complement
32. Distribution and properties of Fc receptors for IgG in different leucocyte populations in man
33. Soluble immune complexes binding to human monocytes and polymorphonuclear leucocytes
34. The human FcR. III. Effects of pronase on soluble immune complex binding by polymorphonuclear leucocytes, monocytes and pulmonary macrophages
35. Fc receptors of a human promyelocytic leukemic cell line: evidence for two types of receptors defined by binding of the staphylococcal protein A-IgGl complex
36. Three dimensional structure of immunoglobulins
37. Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9 and 2.8 Å resolution
38. Crystallographic structural studies of a human Fc-fragment. I. An electron density map at 4 Å resolution and partial model
39. Crystallisation, crystal structure analysis and atomic model of the complex formed by a human Fc fragment and fragment B of protein A from Staphylococcus aureus
40. Identification and fine specificity of Fc receptors on mouse macrophages
41. 2b to the Fc receptor on mouse macrophages
42. Lymphocyte receptors for immunoglobulin
43. Investigation of the binding site of mouse IgG subclasses to homologous peritoneal macrophages
44. Binding sites for Fcγ receptors on immunoglobulin G and factors influencing their expression
45. Functional domains of immunoglobulin G
46. Conformational changes accompanying the dissociation and association of immunoglobulin G subunits
47. Conformational change and complementarity in the combination of H and L chains of immunoglobulin-G
48. The mechanism of binding multivalent immune complexes to Fc receptors: I. Equilibrium binding
49. The mechanism of binding multivalent immune complexes to Fc receptors: II. Kinetics of binding
50. C1q binding to antibody-coated cells: predictions from a simple multivalent model
51. pH gradient elution of human IgG1, IgG2 and IgG4 from protein A-Sepharose
52. Separate pathways of C activation by measles virus cytotoxic antibodies: subclass analysis and capacity of Fab molecules to activate C via the alternative pathway
53. 2 fragment and the intact immunoglobulin
54. Formation of complement subcomponent C1q-immunoglobulin G complexes. Thermodynamic and chemical modification studies
55. Chemical verification of the C1q receptor site on IgG
56. Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-Sepharose
57. The oligosaccharide units of rabbit immunoglobulin G
58. The oligosaccharide units of rabbit immunoglobulin G
59. Tertiary structure of the constant regions of immunoglobulins in relation to their function
60. Human neutrophil Fcγ receptor distribution and structure
61. Monocyte receptors for the Fc portion of IgG studied with monomeric human IgGI: normal in vitro expression of Fcγ-mediated in vivo clearance
62. 2 region of rabbit IgG antibody in immune aggregates
63. The binding of rabbit IgG and its enzymatically derived fragments to homologous peritoneal macrophages
64. Use of staphylococcal protein A as an immunological reagent
65. The mechanism of activation of the first component of complement by a univalent hapten IgG antibody complex
66. 1. II. Binding of human IgG subclass proteins and their proteolytic fragments
67. 1. I. The binding of homologous and heterologous immunoglobulin G
68. Segmental flexibility of immunoglobulin G antibody molecules in solution: a new interpretation
69. Receptors for IgG: subclass specificity of receptors on different mouse cell types and the definition of two distinct receptors on a macrophage cell line
70. Characterization of IgG receptors of the fetal rabbit yolk sac membrane: localization to subcellular fraction and effects of chemical agents and enzymes on binding
71. Immunologically active and structurally similar fragments of protein A from Staphylococcus aureus
72. Rat C1q similarity to human C1q in functional and compositional properties
73. Antibody-induced hemolytic activity of human blood monocytes. The role of antibody class and subclass
74. Crystallographic structure studies of an IgG molecule and an Fc fragment
75. 125I labelled C1q and C1q binders and their use in the measurement of plasma C1q concentrations
76. The reaction between the complement subcomponent C1q, IgG complexes and polyionic molecules
77. Reaction between the isolated globular sub-units of the complement component C1q and IgG complexes
78. The binding and activation of the Clr-Cls subunit of the first component of human complement
79. The effects of chemical modification on the antigenicity of human and rabbit immunoglobulin G
80. 2 fragment of human IgG
81. The structure and function of immunoglublin domains. II. The importance of interchain disulphide bonds and the possible role of molecular flexibility in the interaction between immunoglobulin G and complement
82. 3), (9). (s.t.) and protein A-Sepharose CL-HB
83. Conformational changes induced in a homogeneous anti-type III pneumococcal antibody by oligosaccharides of increasing size
84. The activity and possible significance of anti-immunoglobulin
85. Immunogenic and antigenic epitopes of immunoglobulins VIII. A human monoclonal epitope determined by histidine/ arginine interchange as residue 435 of immunoglobulin G
86. h2 domain of IgG contains the recognition unit for binding by the fetal rabbit yolk sac membrane receptor
87. Effect of reduction and alkylation on structure and function of rabbit IgG antibody. I. Effect on ability to activate complement depends on conditions of reduction
88. 2 fragment for activation of the complement system through the alternative pathway—II. Ionic and indole groups
89. Characterisation of the IgG-Fc receptor on human platelets
90. Dynamics of proteins: elements and functions
91. Increased Fc receptor activity in monocytes from patients with rheumatoid arthritis, a study of monocyte binding and catabolism of soluble aggregates of IgG in vitro
92. Expression of biological effector functions by IgG molecules lacking the hinge region
93. Binding site of human IgG subclasses and their domains for Fc receptors of activated murine T cells
94. Recognition of IgG by Fc receptor and complement: effects of glycosidase digestion
95. The binding of human immunoglobulin G1 monomer and small, covalently cross-linked polymers of immunoglobulin G1 to human peripheral blood monocytes and polymorphonuclear leukocytes
96. Interaction between staphylococcal protein A and immunoglobulin domains
97. Fc receptors of mouse cell lines. I. Distinct proteins mediate the IgG subclassspecific Fc binding activities of macrophages
98. Structural evidence for distinct IgG subclass-specific Fc receptors on mouse peritoneal macrophages
99. Studies on the interaction between protein A and immunoglobulin G. I. Effect of protein A on the functional activity of IgG
100. The effect of aglycosylation on the binding of mouse IgG to staphylococcal protein A
101. Effector functions of a monoclonal aglycosylated mouse IgG2a binding and activation of complement component Cl and interaction with human monocyte Fc receptor
102. The binding of soluble immune complexes of guinea pig IgG2 to homologous peritoneal macrophages. Determination of the avidity constants at 4°C
103. The characterisation of cell receptors for IgG
104. Comparison of the cytophilic activities of guinea pig IgG1 and IgG2 antibodies
105. Species specificity in the binding of immunoglobulin to macrophages
106. On the interaction of rabbit C1q with sheep and rabbit immune complexes
107. On the mechanism of C1q binding to antibody—I. Aggregation and/or distortion of IgG vs combining sitetransmitted effects
108. Interaction of human C1q with insoluble immunoglobulin aggregates
109. The functions of endogeneous C1q, a subcomponent of the first component of complement, as a receptor on the membrane of macrophages
110. Inhibition of C1-mediated immune hemolysis by monomeric and dimeric peptides from the second constant domain of human immunoglobulin G
111. Characteristics and functions of Fc receptors on human lymphocytes
112. Protein binding to brush borders of enterocytes from the jejunum of the neonatal rat
113. The binding of proteins to isolated enterocytes from the small intestine of the neonatal rat
114. The binding of murine immunoglobulins to staphylococcal protein A
115. Effector activating determinants on IgG. II. Differentiation of the combining sites for C1q from those of cytotoxic K cells and neutrophils by plasmin digestion of rabbit IgG
116. Effector activating determinants on IgG. I. The distribution and factors influencing the display of complement neutrophil and cytotoxic ‘B’ cell determinants on human IgG subclasses
117. Crystallographic refinement and atomic models of the intact immunoglobulin molecule Kol and its antigenbinding fragment at 3.0 and 1.9 Å resolution
118. Separation of guinea pig IgG subclasses by affinity chromatography on protein A-Sepharose
119. Similarities of Fc receptors on trophoblasts and placental endothelial cells
120. Repeating sequences and gene duplication in proteins
121. Fc receptors of rat peritoneal macrophages: immunglobulin class specificity and sensitivity to drugs affecting the microfilament or microtubule system
122. Classes and subclasses of rat immunoglobulins: interaction with the complement system and with staphylococcal protein A
123. Purification of a functional mouse Fc receptor through the use of a monoclonal antibody
124. The effect of antigen on antibodies: recent studies
125. Structural requirements in the Fc region of rabbit IgG antibodies necessary to induce cytotoxicity by human lymphocytes
126. Structural and numerical variations of the carbohydrate moiety of immunoglobulin G
127. Fc-mediated immune precipitation. I. A new role for the Fc-portion of IgG
128. Fc-mediated immune preciptation. II. Analysis of precipitating immune complexes by rate-zonal ultracentrifugation
129. H3 domain of human IgG1
130. Enhancement of T lymphocyte functions by Fc fragments of immunoglobulins. I. Augmentation function by Fc fragments of immunoglobulins. I. Augmentation of allogeneic mixed lymphocyte culture reactions requires I-A- or I-B-subregion differences between effector and stimulator cell populations
131. Enhancement of T-lymphocyte functions by Fc fragments of immunoglobulin
132. Regulation of Fc fragment-induced murine spleen cell proliferation
133. Complement
134. Specificity of Fc receptors of activated T cells Relation with released immunoglobulin binding factor
135. Human placental membrane receptor of IgG I Studies on properties and solubilisation of the receptor
136. Immunogenic and antigenic epitopes of immunoglobulins—V Reactivity of a panel of monoclonal antibodies with sub-fragments of human Fcγ and abnormal paraproteins having deletions
137. Immunogenic and antigenic epitopes of immunoglobulins—VII, The topographical distribution of Feγ epitopes and the relationship of an iso-allotypic specificity to the presence of histidine 435
138. Biological significance of carbohydrate chains on monoclonal antibodies
139. Correlation between segmental flexibility and effector function of antibodies
140. Localization of monocyte binding site of human immunoglobulin G
141. Reconstitution of 7S molecules from L and H polypeptide chains of antibodies and γ-globulins
142. Biologic activities of rabbit immunoglobulin G in relation to domains of the Fc region
143. Functional affinity constants of subfragments of IgG for C1q
144. Functional affinity constants of subfragments of immunoglobulin G for C1q
145. Conformational changes and complement activation induced upon antigen binding to antibodies
146. 2 within Cl
147. Three dimensional structure of the pFc' fragment of guinea pig IgG1
148. Effect of cleaving interchain disulphide bridge on the radius of gyration and maximum length of antipoly (d-alanyl) antibodies before and after reaction with tetraaniline hapten
149. Correlation between three-dimensional structure and function of immunoglobulins
150. Conformation and restricted segmental flexibility of Cl, the first component of human complement
151. Inhibition of the classical complement pathway by synthetic peptides from the second constant domain of the heavy chain of IgG
152. Structural, functional and conformation analysis of immunoglobulin G-derived asparagine-linked oligosaccharides
153. Threedimensional structure of the Mcg IgG1 immunoglobulin
154. H3 domain of IgG as binding site to Fc receptor on mouse lymphocytes
155. The use of synthetic gamma chain peptides in the localisation of the binding site(s) on human IgG1 for the Fc receptors of homologous monocytes and heterologous mouse macrophages
156. The localisation of the binding sites on human IgG1 for the Fc receptors on homologous monocytes and heterologous mouse macrophages
157. Structural studies of a human γ3 myeloma protein (Goe) that binds staph protein A
158. Proteins involved in the activation and control of the two pathways of human complement
159. The protcolytic activation systems of complement
160. Rotational dynamics of monoclonal anti-dansyl immunoglobulins
161. Heterogeneity of Fc-receptors on guinea-pig T lymphocytes
162. Isotype specificity of Fcγ-receptors on guinea-pig T lymphocytes and their modulation by homologous immune complexes
163. Packing of α-helices geometrical constraints and contact areas
164. pH dependent binding of immunoglobulins to intestinal cells of the neonatal rat
165. Antigen valence and Fc-localised secondary forces in antibody precipitation
166. Conversion of incomplete antibodies to direct agglutinins by mild reduction: evidence for segmental flexibility with the Fc fragment of immunoglobulin G
167. Two distinct Fc receptors for IgG on human peripheral T lymphocytes
168. A three-dimensional structure of a human IgG1 immunoglobulin at 4 Å resolution a computer fit of various structural domains on the electron density map
169. Preliminary refinement and structural analysis of the Fab fragment from human immunoglobulin New at 2.0 Å resolution
170. Characterisation of ligand binding activity of isolated murine Fcγ receptor
171. Ultracentrifuge studies of the binding of IgG of different subclasses to the C1q subunit of the first component of complement
172. Changes in quaternary structure of IgG upon reduction of the interheavy chain disulphide bond
173. Binding of affinity cross-linked oligomers of IgG to cells bearing Fc receptors
174. The subclass specificity for the binding of murine myeloma proteins to macrophage and lymphocyte cell lines and to normal spleen cells
175. Three-dimensional structure of an intact human immunoglobulin
176. The first component of human complement Cl
177. 2 and Fab' fragments
178. Repetitive sequences in protein A from Staphylococcus aureus: three highly homologous Fcbinding regions
179. Repetitive sequences in protein A from Staphylococcus aureus. Arrangement of five regions within the protein, four being highly homologous and Fc-binding
180. Structural studies on the four repetitive Fc-binding regions in protein A from Staphylococcus aureus
181. Binding properties of human complement protein C1q
182. Attachment of carbohydrate to the variable region of myeloma immunoglobulin light chains
183. Consumption of human complement components by complexes by IgG with protein A of Staphylococcus aureus
184. A requirement for native (undenatured) IgG for detection of species specificity of the IgG-Fc receptor on lymphocytes
185. Ultrastructure of the first component of human complement: electron microscopy of the cross-linked complex
186. Evidence for two distinct Fc receptors on guinea pig peritoneal macrophages
187. IgG-binding sites on macrophage cell membrane. I. Identification of two distinct Fc receptors on mouse peritoneal macrophages
188. Effects of protein A Staphylococcus aureus on the binding of monomeric and polymeric IgG to Fc receptor-bearing cells
189. The three-dimensional structure of the carbohydrate within the Fc fragment of immunoglobulin G
190. 1
191. Polyclonal activation of murine B lymphocytes by Fc fragments. II. Replacement of T cells by a soluble helper T cell-replacing factor (TRF)
192. − T lymphocytes to release a helper T cell replacing activity
193. Binding of IgG and papain-derived fragments to Fc receptors of the fetal rabbit yolk sac membrane
194. Antigen-independent activation of the first component of complement Cl by chemically cross-linked rabbit IgG oligomers
195. Assembly of subcomponents Cl r and Cl s of first component of complement Electron microscopic and ultracentrifugal studies
196. Antigen-independent binding of IgG dimers to C1q as studied by sedimentation equilibrium, complement fixation, and electron microscopy
197. Structure and function of immunoglobulins
198. Binding of monomeric immunoglobulins to Fc receptors of mouse macrophages
199. Structural aspects and heterogeneity of immunoglobulin Fc receptors
200. Electron microscopy of an antibody-hapten complex
201. The Fcγ receptor on human placental plasma membrane. I. Studies on the binding of homologous and heterologous immunoglobulin G
202. Staphylococcal protein A and human IgG subclasses and allotypes
203. The role of interchain disulphide bridges in the conformational stability of human immunoglobulin Gl subclass. Hydrogendeuterium exchange studies
204. Hapten-induced structural changes in rabbit immunoglobulin G. with specifically mercuriated interheavy chain disulphide
205. Separate Fc receptors for immunoglobulin IgG2a and IgG2b on an established cell line of mouse macrophages
206. Studies on the IgG Fc-fragment receptor from neonatal rat small intestine
207. Studies of biologic and serologic activities of rabbit-IgG antibody depleted of carbohydrate residues
208. Immunoglobulin structure and effector functions
209. Effects of pH treatments and deglycosylation of rabbit immunoglobulin G on the binding of C1q
210. The monocyte binding domain(s) on human immunoglobulin G
211. Dimeric, trimeric and tetrameric complexes of immunoglobulin G fix component
212. Electron microscopic evidence for the axial rotation and interdomain flexibility of the Fab regions of immunoglobulin G
213. The structure and function of immunoglobulin domains. IV. The distribution of some effector functions among the Cγ2 and Cγ3 homology regions of human immunoglobulin G
214. Segmental flexibility in an antibody molecule
215. Activation of Clr by proteolytic cleavage